iifl-logo-icon 1

Unichem Laboratories Ltd Annually Results

718.15
(-1.56%)
Feb 10, 2025|11:44:57 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,785.11

1,343.02

1,269.83

1,235.14

1,103.71

Excise Duty

0

0

0

0

0

Net Sales

1,785.11

1,343.02

1,269.83

1,235.14

1,103.71

Other Operating Income

0

0

0

0

0

Other Income

31.59

38.52

47.51

50.19

92.13

Total Income

1,816.7

1,381.54

1,317.34

1,285.32

1,195.84

Total Expenditure

1,755.84

1,427.14

1,198.1

1,144.37

1,154.53

PBIDT

60.86

-45.61

119.24

140.95

41.31

Interest

22.66

17.31

6.11

5.12

7.85

PBDT

38.2

-62.92

113.14

135.84

33.46

Depreciation

123.16

113.44

91.17

84.36

81.67

Minority Interest Before NP

0

0

0

0

0

Tax

7.94

10.51

10.75

17.3

5.47

Deferred Tax

0.86

15.35

-21.84

-0.15

6.5

Reported Profit After Tax

-93.76

-202.23

33.06

34.32

-60.18

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-93.76

-202.23

33.06

34.32

-60.18

Extra-ordinary Items

-51.64

-32.91

0

0

0

Adjusted Profit After Extra-ordinary item

-42.12

-169.32

33.06

34.32

-60.18

EPS (Unit Curr.)

-13.32

-28.72

4.7

4.88

-8.55

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

200

200

200

Equity

14.08

14.08

14.08

14.08

14.08

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

3.4

-3.39

9.39

11.41

3.74

PBDTM(%)

2.13

-4.68

8.9

10.99

3.03

PATM(%)

-5.25

-15.05

2.6

2.77

-5.45

Unichem Labs.: Related NEWS

Unichem Labs Q3 Profit Drops 20.5% YoY, Revenue Up 14.5%
6 Feb 2025|10:48 PM

Revenue increased by 14.5% to ₹533 crore from ₹466 crore the previous year.

Read More
Unichem Labs plans to consolidate US generic formulations bizz
23 Sep 2024|03:02 PM

Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.

Read More
Unichem Labs Goa facility gets 5 observations from USFDA
16 Jul 2024|11:11 AM

According to the corporation, the observations have no influence on business continuity or supplies to the US market.

Read More
Top 10 stocks for today - 16th July, 2024
16 Jul 2024|08:47 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.